Abstract Objective: to detect the possible cardioprotective effect of Ang-(1-7) in rat model of MI; Also, possible role of NO and PGs in this probable cardioprotective effect of Ang-(1-7) was studied. Methods: Rats were divided randomly into 6 groups (8 rats each): Group I : Control group:, Group II: rats received S.C isoprenaline at a dose of 150 mg/kg/day on two consecutive days with an interval of 24 hours between applications, Group III: rats received Ang (1-7) (576μg/kg/day) S.C for 6 days after induction of MI ,Group IV: in which rats received Ang (1-7) (576μg/kg/day)+ L-NAME in the drinking water (80 mg/l) for 6days after induction of MI ,Group V: in which rats received Ang (1-7) (576μg/kg/day) +Indomethacin 5 mg/kg/day IP for 6 days after induction of MI ,Group VI: in which rats received both Ang-(1-7)+ L-NAME and Indomethacin at dose mentioned previously. Biochemical, histopathologial , and ECG changes were studied Results: ISO -MI group exhibited a significant rise in serum cardiac enzymes and disturbed lipid profile, increased myocardial damage score and Caspase3 expression when it is compared to the normal group (p<0.001). ECG changes of rat revealed elevation ST segment, QT interval prolongation, decrease QRS duration and voltage, and accelerated heart rate. Ang-(1-7) caused significant improvement in the studied parameters ,while co-infusion of L-NAME and or indomethacin prevent this effect of Ang-(1-7) .Combined L-NAME and indomethacin produce more deleterious effect than separate administration of them. Conclusion: Ang-(1-7) is considered one of the cardioprotective components of RAS .NO and PGs mediate the action of Ang-(1-7) and they may have an additive effect. 
Introduction
Cardiovascular diseases are considered one of the most common causes of mortality and morbidity all over the world (1). Myocardial infarction (MI) is considered among the most serious acute lesion affecting the heart, that cause hundreds of thousands of deaths annually worldwide (2).Thus, the continuous studies about the strategies of therapies that can reduce the occurrence of this pathology is still mandatory (3).
The pathophysiology of MI comprises different mechanisms in which RAS play an effective role. The RAS are more complex than previously known, it has two major types of function, according to the type of peptides produced ; a proliferative &vasoconstrictor one in which the major acting peptide is (Ang II) and an anti-proliferative& vasodilator one in which the major effector is Ang-(1-7) (4).
Since it has been identified, Ang-(1-7) has rapidly gained a great position as one of the remarkable cardioprotective molecules in RAS (5).Ang-(1-7) is an active heptapeptide of the RAS; its physiological role are mostly opposite to that produced by Ang II. It binds to specific G protein coupled receptor named MAS receptor (the name is the first 3-surname letters of the patient whose tumor cells were used to identify the gene) (4).
Ang-(1-7) may act either by a direct mechanism on its receptor, or indirectly through bradykinin potentiation (6),-NO and prostaglandin release (7).Also, Ang-(1-7) can inhibit ACE (8),so it was suggested that this heptapeptide could be a target to discover new and innovative cardioprotective drugs (7).
Ang-(1-7) may produce many beneficial functions in the heart, including: vasodilation, inhibition of cell proliferation, prevention of hypertrophy, reducing fibrosis, inhibition of thrombosis, and prevention of arrhythmia (8).
Following activation of MAS by Ang-(1-7) in the heart, the signal transduction pathways are not fully characterized, however it may involve release of PGs and or NO release or both (4).
In contrast to many studies that reported a cardioprotective role of Ang-(1-7), it has been reported that Ang-(1-7) infusion resulted in harmful events occurred in the heart of Sprague dawley rats (10). Also, Zhang et al. Indomethacin has been used as a potent nonsteroidal anti-inflammatory drug that acts through inhibition of cyclooxygenase thus preventing the production of prostaglandins from arachidonic acid
(20).
So the aim of this work was to determine the possible cardioprotective role of Ang-(1-7) in rat model of MI; through studying electrocardiographic, biochemical and histopathological changes in those rats. Also, possible role of NO and PGs in this probable cardioprotective effect of Ang-(1-7) was studied.
Materials and Methods

Chemicals:
Angiotensin Fragment 1-7 acetate salt hydrate, L-NAME hydrochloride, Indomethacin, isoproterenol hydrochloride, Ketamine hydrochloride, Xylazine hydrochloride were obtained from Sigma Chemical Co., St. Louis, MO, USA.
Animals:
Forty eight adult male SD rats aging 4-6 months, and weighing between 200-250 g were used in the thesis. (1-7) (576μg/kg/day) S.C for 6 days after induction of MI (22).Group IV (ISO-induced MI + Ang-(1-7) + L-NAME): rats received Ang-(1-7)
at the same previous dose + L-NAME in the drinking water (80 mg/l) for 6days after induction of MI (22).Group V (ISO-induced MI + Ang-(1-7) +Indomethacin): rats received Ang-(1-7) at the same previous dose + Indomethacin 5 mg/kg/day IP for 6 days after induction of MI(23).Group VI (ISO-induced MI + Ang-(1-7) +Indomethacin+ L NAME): rats received both Ang-(1-7) +L-NAME and indomethacin at the same previous dose (24).
Recording of ECG
For all rats in this study, recording of ECG was done at basal day and repeated at the second and eighth days after MI induction in all experimental rats. Light ether anesthesia was used during ECG recording .biopac student lab system (software BSL 3.7.5), MP45 ( data acquisition unit), biopac electrode lead set x2 and disposable vinyl electrodes, 3 electrodes for each rat were used during ECG recording.
Measurement of cardiac enzymes (CK-MB, AST ,-ALT , and LDH)
Cardiac enzymes were measured using commercially available kits according to the manufacturer's instructions. AST, ALT and CK-MB kits were purchased from bioMérieux Diagnostics, Milan, Italy,-while LDH kits were purchased from Bayer Diagnostics Ltd., Baroda, India.
Assay of lipid profile
The lipid profile measured parameters include triglycerides, cholesterol, HDL-CL, and LDL-CL.
They were determined by using available kits according to the manufacturer's instructions. Kits were purchased from Spinreact Company, Sant
Esteve de Bas, groupGirona, Spain.
Histopathological examination
The cardiac tissues from all rats were washed with saline immediately and fixation in 10% buffered neutral formalin solution was performed, and then embedded in paraffin. The cardiac tissue was sectioned and stained with haematoxylin and eosin (H&E). The results were classified as no changes; +mild (slight cardiomyocyte damage with mild degree of inflammation); ++moderate (excess cardiomyocyte degeneration in association with diffuse inflammation); +++marked (sever necrosis with extensive inflammation). According to these histopathological changes in myocardium; rats were graded into three distinct groups: group A (with no histopathological change), group B (mild affection) and group C (moderate and/or severe affection).
Immunohistochemical detection of caspase 3
Polyclonal antibody of rabbit was used 
Statistical analysis
The obtained data were represented as Mean ± The results were represented as mean ± SD, testes used are One way ANOVA and Turkey's post hoc (p≤ 0.05 is considered), NC = normal group, ISO=Isoprenaline, Both= L-NAME+ INDOMETHACIN, €=significant in comparison to basal group, Ω = significant significant in comparison to 2 days group, # = significant significant in comparison to 8 days group, A = significant vs. NC, B significant vs. Iso group, C = significant vs. ang1-7, D= significant vs. L-NAME,E =significant vs indomethacin,F= significant vs Both. The results were represented as mean ± SD, testes used are One way ANOVA and Turkey's post hoc (p≤ 0.05 is considered), NC = normal group, ISO=Isoprenaline, Both= L-NAME+ INDOMETHACIN, €=significant in comparison to basal group, Ω = significant significant in comparison to 2 days group, # = significant significant in comparison to 8 days group, A = significant vs. NC, B significant vs. Iso group, C = significant vs. ang1-7, D= significant vs. L-NAME,E =significant vs indomethacin,F= significant vs Both.
At day 8, serum Cholesterol, TG, LDL-CL were decreased significantly in Ang-(1-7) treated group when compared to ISO group as well as to L-NAME, indomethacin, combined (L-NAME& indomethacin) treated groups (p≤ 0.001) ,also HDL-CL was increased significantly in Ang-(1-7) treated group when compared to ISO group as well as to L-NAME, indomethacin, combined (L-NAME & indomethacin) treated groups (p≤ 0.001), Furthermore serum Cholesterol and TG were increased significantly in combined group when compared to L-NAME, indomethacin groups.
Effect of Ang-(1-7), Ang-(1-7) +LNAME, Ang- The results were represented as mean ± SD, testes used are One way ANOVA and Turkey's post hoc (p≤ 0.05 is considered), NC = normal group, ISO=Isoprenaline, Both= L-NAME+ INDOMETHACIN, €=significant in comparison to basal group, Ω = significant significant in comparison to 2 days group, # = significant significant in comparison to 8 days group, A = significant vs. NC, B significant vs. Iso group, C = significant vs. ang1-7, D= significant vs. L-NAME,E =significant vs indomethacin,F= significant vs Both.
Effect of Ang-(1-7), Ang-(1-7) +LNAME, Ang-
(1-7) +Indomethacin Ang-(1-7) +both(L-NAME &Indomethacin) on myocardial morphology :
Pathological finding of different groups are represented in table (4). The histopathological changes score from all rats of the control group was A.-On the other hand, In SO-MI group, about 63% of rats became score C. The Ang-(1-7) treated group exhibited remarkable decrease in the damage score as about 63% of rats became score A.In Ang-(1-7) +L-NAME, Ang-(1-7)
+Indomethacin Ang-(1-7) about 63%,75% of rats respectively became score C. In combined group about 87% of rats became score C. Figure (1-7) resulted in slight degeneration of myocardium (Fig.4c) . L-NAME and indomethacin produce edema of the interstitial tissue with infiltration of neutrophil and moderate muscle fiber degeneration (Fig.4d&e ) when coadministrated with Ang1-7,on the other hand combined L-NAME and indomethacin (Fig.4f) resulted in sever edema of the interstitial tissue with marked infiltration of neutrophil indicating sever cardiomyocyte damage.-Noteworthy combined L-NAME and indomethacin administration produced more severe damage of myocardium than each one done separately. Figure 4 : Specimens of the heart showing a) Normal structure of rat myocardium (control group), b) Infarcted zone with edema of the interstitial tissue with excess neutrophil indicating sever cardiomyocyte damage (ISO-MI group), c) zone of infarction with edema of the interstitial tissue ,mild infiltration of neutrophil and mild myofibrillary degeneration (ISO+Ang-(1-7)), d) edema of the interstitial tissue with moderate infiltration of neutrophil and moderatecardiomyoctes damage (ISO+ Ang-(1-7) +L-NAME group), e) edema of the interstitial tissue with moderate infiltration of neutrophil and moderatecardiomyoctes damage (ISO+ Ang-(1-7) +indomethacin group) and f) edema of the interstitial tissue with excessive infiltration of neutrophil and excessive cardiomyoctes damage (ISO+both group) (H&E, 200X).
Effect of Ang-(1-7), Ang-(1-7) +LNAME, Ang- Caspase 3 was decreased significantly in Ang1-7 treated group when compared to ISO-MI group as well as to L-NAME, indomethacin, combined (L-NAME& indomethacin) treated groups (p≤ 0.001).
Caspase 3 increased significantly in combined treated group when compared to L-NAME, indomethacin groups (p≤ 0.001). The results were represented as mean ± SD, testes used are One way ANOVA and Turkey's post hoc (p≤ 0.05 is considered), NC = normal group, ISO=Isoprenaline, Both= L-NAME+ INDOMETHACIN, a = significant vs. NC, b significant vs. Iso group, c = significant vs. ang1-7, d= significant vs. L-NAME,e =significant vs indomethacin,f= significant vs BOTH. The results of the current study showed high serum levels of cardiac enzymes in ISOtreated groups indicating cardiomyocytes damage. These results were in line with studies before (27, 28, 29) .These results could be explained by cytoskeleton disorganization (30), cellular damage and loss of functional integrity and permeability of cell membrane (31).
Ang-(1-7) treated group showed decreased serum levels of cardiac enzymes denoting cardioprotective effect of this heptapeptide.
These finding were in agreement with other studies (30, 32, 33) .The decrease in these cytosolic enzymes may be explained by Ang- On the other hand co-infusion of L-NAME and or indomethacin with Ang-(1-7)
reverse this cardioprotective effect of Ang-(1-7) indicating that Ang-(1-7) action is mediated through NO (57,58) or PGs (59) or both (7). Immunohistochemical expression of activated
